Lab-Grown mini tumors could unlock personalized pancreatic cancer care
NCT ID NCT06666803
First seen Apr 25, 2026 · Last updated Jun 11, 2026 · Updated 6 times
Summary
This study aims to grow miniature versions of pancreatic tumors (called organoids) from small biopsy samples taken during a routine endoscopic procedure. Researchers will check if these lab-grown organoids match the original tumor's genetics and behavior. The goal is to eventually use these organoids to test which drugs might work best for each patient, but this study is focused on proving the method works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre d'Endoscopie Digestive
RECRUITINGStrasbourg, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of hepato-gastroenterology
RECRUITINGStrasbourg, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.